IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Delirium

Review Article, Volume 03 Issue 2 – April to June 2010

Authors

Dr. Smitha Ramadas, Associate Professor and Consultant Psychiatrist1.
1Department of Psychiatry, Government Medical College, Thrissur, Kerala.


Abstract

Delirium is an acute, potentially reversible brain dysfunction manifested by a syndromal array of neuropsychiatric symptoms. It is often under diagnosed, under recognized and preventable. Non-detection in emergency departments is associated with a sevenfold hazard for increased mortality,
It is a syndrome of acute onset, fluctuating course and brief duration (usually days to weeks). The severity of symptoms fluctuates over 24 hour period with lucid intervals in between.
Pharmacological management is based on the notion of a relative dopamine excess and cholinergic deficiency as the principal neurochemical aberrations underlying delirium. Haloperidol remains the standard agent used to treat delirium.
Though delirium is a medical emergency, more than 50% of cases are missed, misdiagnosed or diagnosed late. Therefore increased awareness about the condition among health care professionals is needed.
Keywords: Delirium, Clinical features, Management, Haloperidol, Delirium tremens.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician